A broad and potent neutralization epitope in SARS-related coronaviruses
Many neutralizing antibodies (nAbs) elicited to ancestral severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced …
coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced …
[PDF][PDF] A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuana, X Zhua, W Heb, P Zhoub, CI Kakue… - 2022 - researchgate.net
Results Crystal Structure of ADG20 in Complex with SARS-CoV-2 RBD. Some of the authors
previously developed mAb ADG20 as an extended half-life version of potent-and-broad …
previously developed mAb ADG20 as an extended half-life version of potent-and-broad …
A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku… - Proc. Natl. Acad. Sci …, 2022 - osti.gov
A broad and potent neutralization epitope in SARS-related coronaviruses (Journal Article) |
OSTI.GOV skip to main content Sign In Create Account Show search Show menu OSTI.GOV …
OSTI.GOV skip to main content Sign In Create Account Show search Show menu OSTI.GOV …
[PDF][PDF] A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola… - scienceopen.com
A broad and potent neutralization epitope in SARS-related coronaviruses Page 1 1 A broad
and potent neutralization epitope in SARS-related coronaviruses Meng Yuan1,*, Xueyong …
and potent neutralization epitope in SARS-related coronaviruses Meng Yuan1,*, Xueyong …
A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku… - Proceedings of the …, 2022 - ui.adsabs.harvard.edu
Since the beginning of the COVID-19 pandemic, many severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) variants have emerged that are resistant to varying extents to …
coronavirus 2 (SARS-CoV-2) variants have emerged that are resistant to varying extents to …
A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, WT He, P Zhou… - Proceedings of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Many neutralizing antibodies (nAbs) elicited to ancestral severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced …
coronavirus 2 (SARS-CoV-2) through natural infection and vaccination have reduced …
A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola… - 2022 - pesquisa.bvsalud.org
A broad and potent neutralization epitope in SARS-related coronaviruses | PREPRINT-BIORXIV
loading 1 2 3 +A A -A 3.A broad and potent neutralization epitope in SARS-related coronaviruses …
loading 1 2 3 +A A -A 3.A broad and potent neutralization epitope in SARS-related coronaviruses …
[HTML][HTML] A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku… - Proceedings of the …, 2022 - ncbi.nlm.nih.gov
Results Crystal Structure of ADG20 in Complex with SARS-CoV-2 RBD. Some of the authors
previously developed mAb ADG20 as an extended half-life version of potent-and-broad …
previously developed mAb ADG20 as an extended half-life version of potent-and-broad …
A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola… - bioRxiv, 2022 - biorxiv.org
Many neutralizing antibodies (nAbs) elicited to ancestral SARS-CoV-2 through natural
infection and vaccination generally have reduced effectiveness to SARS-CoV-2 variants …
infection and vaccination generally have reduced effectiveness to SARS-CoV-2 variants …
[HTML][HTML] A broad and potent neutralization epitope in SARS-related coronaviruses
M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola… - 2022 - europepmc.org
Many neutralizing antibodies (nAbs) elicited to ancestral SARS-CoV-2 through natural
infection and vaccination generally have reduced effectiveness to SARS-CoV-2 variants …
infection and vaccination generally have reduced effectiveness to SARS-CoV-2 variants …